Back to search
Latent Autoimmune Diabetes in Adult (LADA)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Latent Autoimmune Diabetes in Adult (LADA) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Latent Autoimmune Diabetes in Adult (LADA) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
After obtaining informed consent, the investigators will recruit 75 patients with T1DM and 75 with LADA with an age ≥ 18 years and ≤ 75 years, of both sexes. Al…
The challenges of living with type 1 diabetes often stand in the way of getting enough exercise. Continuous blood sugar monitoring has revolutionized type 1 dia…
Based on the difficulties in blood glucose control among the Latent Autoimmune Diabetes in Adults (LADA) population and the deficiencies of previous studies, th…
This single-center, randomized, open-label, controlled study aims to evaluate the effect of cofrogliptin on pancreatic β-cell function in adults with latent aut…
The goal of this observational cross-sectional study is to assess the prevalence and stage of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD),…